About Benvenue Medical
Founded in 2004, Benvenue Medical, Inc., provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.
Benvenue Medical has developed next-generation, minimally invasive implants and devices for the spine based on proprietary flexible Peek and pre-shaped Nitinol technologies.
Kiva® VCF Treatment System is a unipedicular, PEEK-OPTIMA® implant solution for vertebral augmentation and a departure from balloon kyphoplasty, making it the first new approach to the treatment of vertebral compression fractures in over a decade.
Blazer-C® is a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, predictable cement deposition across the entire vertebral body and an MIS unilateral approach.
Luna® 3D is a multi-expandable, PEEK® interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ, first to an ALIF-sized footprint and then expands up to 15mm in height.
Our Vision
Be the global leader in minimally invasive restoration of the natural curvature of the spine.
Our Mission
Benvenue Medical develops next generation minimally invasive expandable implant systems for the spine, supported by clinical data.
Management Team
Robert Weigle | CEO
Robert Weigle joined Benvenue Medical in 2009 and brings over 20 years of experience in medical devices, including relevant neuro/spine experience at Johnson & Johnson, Baxter, Aesculap, and Neurocare.
Laurent Schaller | Founder & Chief Technical Officer
Laurent Schaller has over 20 years of experience in the medical device industry, with a focus on development of interventional/catheter-based tools, micro devices, and surgical products. He has played key roles with companies such as Target Therapeutics, Cardima, and Coalescent Surgical.
Rick Simmons | Vice President of Sales and Marketing
Rick Simmons joined the company in 2014 and brings over 30 years of commercialization experience in the medical device industry. Rick has held leadership roles at TranS1, NuVasive, Innovasive Devices, Acufex, and most recently was President of g2m MedTech Advisors.
